If additional analyses are ordered, laboratories can rapidly identify the patient information, see any previous testing carried out on the sample and by whom, and easily export sample histories for further review or audit purposes. Sample tracking solutions enable research teams and laboratories to know precisely where samples are in a clinical trials’s testing process.
#Labkey sample manager manual#
Virtual accessioning allows the trial’s sponsors and staff to confirm which samples were collected and to check each specimen’s data and status in real time, reducing miscommunications, manual errors, and the number of queries sent to the study site. Encrypted handwritten data associated with the sample’s identification number is then transmitted to a digital database through a USB port. Users write with the pen, which contains real ink, to simultaneously fill out paper requisition forms and capture data at the point of sample collection. This tool records subject, visit, and sample information with no need for physical laboratory requisition and samples. One tool used for this purpose is the digital pen, like the LabConnect’s digital ink pen.
#Labkey sample manager trial#
Initiating the sample journey in a clinical trial with virtual sample accessioning (instead of manual or spreadsheet-based systems) provides several quality assurance opportunities, including more complete and accurate data, greater sample integrity, and improved sample security. The benefits of virtual sample accessioning Read on for an overview of devices and systems used to improve efficiency in clinical trial operations. Improved sample and data management is becoming easier to accomplish with technological advances and modern digital data management processes. As trial sponsors, whether academic institutions, companies, or contract research organizations, continue to preserve a larger number of biological specimens for future research efforts, tracking and managing patient samples requires considerable work and coordination. Laboratory data collection and management in clinical trials are becoming increasingly complex, especially in multicenter or biomarker-guided trials.
0 kommentar(er)
